NVO logo

Novo Nordisk A/S (NVO) Revenue

Annual revenue:

$42.12B+$8.41B(+24.97%)
December 31, 2024

Summary

  • As of today (August 21, 2025), NVO annual revenue is $42.12 billion, with the most recent change of +$8.41 billion (+24.97%) on December 31, 2024.
  • During the last 3 years, NVO annual revenue has risen by +$19.74 billion (+88.20%).
  • NVO annual revenue is now at all-time high.

Performance

NVO Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

Quarterly revenue:

$11.68B+$667.23M(+6.06%)
June 1, 2025

Summary

  • As of today (August 21, 2025), NVO quarterly revenue is $11.68 billion, with the most recent change of +$667.23 million (+6.06%) on June 1, 2025.
  • Over the past year, NVO quarterly revenue has increased by +$1.86 billion (+18.96%).
  • NVO quarterly revenue is now -4.65% below its all-time high of $12.25 billion, reached on December 31, 2024.

Performance

NVO Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

TTM revenue:

$45.45B+$1.86B(+4.27%)
June 1, 2025

Summary

  • As of today (August 21, 2025), NVO TTM revenue is $45.45 billion, with the most recent change of +$1.86 billion (+4.27%) on June 1, 2025.
  • Over the past year, NVO TTM revenue has increased by +$8.05 billion (+21.52%).
  • NVO TTM revenue is now at all-time high.

Performance

NVO TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVOincome statement metrics

NVO Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+25.0%+19.0%+21.5%
3 y3 years+88.2%+97.9%+91.2%
5 y5 years+130.2%+163.7%+142.6%

NVO Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+88.2%-4.7%+97.9%at high+91.2%
5 y5-yearat high+130.2%-4.7%+163.7%at high+142.6%
alltimeall timeat high>+9999.0%-4.7%>+9999.0%at high>+9999.0%

NVO Revenue History

DateAnnualQuarterlyTTM
Jun 2025
-
$11.68B(+6.1%)
$45.45B(+4.3%)
Mar 2025
-
$11.02B(-10.1%)
$43.59B(+3.6%)
Dec 2024
$42.12B(+25.0%)
$12.25B(+16.7%)
$42.09B(+7.0%)
Sep 2024
-
$10.50B(+6.9%)
$39.33B(+5.2%)
Jun 2024
-
$9.82B(+3.3%)
$37.40B(+5.3%)
Mar 2024
-
$9.51B(+0.2%)
$35.52B(+5.4%)
Dec 2023
$33.70B(+34.8%)
$9.50B(+10.8%)
$33.70B(+9.4%)
Sep 2023
-
$8.57B(+8.1%)
$30.79B(+8.5%)
Jun 2023
-
$7.93B(+3.1%)
$28.39B(+7.7%)
Mar 2023
-
$7.69B(+16.6%)
$26.36B(+5.4%)
Dec 2022
$25.00B(+11.7%)
$6.59B(+7.0%)
$25.00B(+2.9%)
Sep 2022
-
$6.17B(+4.5%)
$24.30B(+2.2%)
Jun 2022
-
$5.90B(-6.8%)
$23.78B(+2.4%)
Mar 2022
-
$6.34B(+7.6%)
$23.23B(+3.9%)
Dec 2021
$22.38B(+15.3%)
$5.89B(+4.3%)
$22.37B(+3.4%)
Sep 2021
-
$5.65B(+5.4%)
$21.63B(+3.8%)
Jun 2021
-
$5.36B(-2.2%)
$20.83B(+4.7%)
Mar 2021
-
$5.47B(+6.4%)
$19.91B(+2.5%)
Dec 2020
$19.41B(+6.1%)
$5.15B(+6.0%)
$19.43B(+1.8%)
Sep 2020
-
$4.86B(+9.6%)
$19.08B(+1.8%)
Jun 2020
-
$4.43B(-11.3%)
$18.74B(-0.5%)
Mar 2020
-
$4.99B(+4.0%)
$18.83B(+2.9%)
Dec 2019
$18.29B(+3.3%)
$4.80B(+6.5%)
$18.29B(+1.4%)
Sep 2019
-
$4.51B(-0.2%)
$18.03B(+1.0%)
Jun 2019
-
$4.52B(+1.4%)
$17.85B(+0.8%)
Mar 2019
-
$4.46B(-2.0%)
$17.72B(+0.1%)
Dec 2018
$17.70B(+4.5%)
$4.55B(+5.0%)
$17.70B(+0.7%)
Sep 2018
-
$4.33B(-1.2%)
$17.59B(+0.7%)
Jun 2018
-
$4.38B(-1.4%)
$17.46B(+0.8%)
Mar 2018
-
$4.44B(+0.4%)
$17.32B(+2.2%)
Dec 2017
$16.94B(+2.0%)
$4.43B(+5.4%)
$16.95B(+0.9%)
Sep 2017
-
$4.20B(-0.9%)
$16.81B(+0.4%)
Jun 2017
-
$4.24B(+4.0%)
$16.73B(+0.4%)
Mar 2017
-
$4.08B(-4.8%)
$16.66B(+0.3%)
Dec 2016
$16.61B(+3.5%)
$4.28B(+3.7%)
$16.60B(+0.3%)
Sep 2016
-
$4.13B(-0.9%)
$16.55B(+0.8%)
Jun 2016
-
$4.17B(+3.6%)
$16.42B(+1.0%)
Mar 2016
-
$4.02B(-5.1%)
$16.26B(+1.4%)
Dec 2015
$16.05B(+1.5%)
$4.24B(+6.1%)
$16.04B(+0.7%)
Sep 2015
-
$3.99B(-0.5%)
$15.93B(+0.2%)
Jun 2015
-
$4.01B(+5.5%)
$15.90B(+0.2%)
Mar 2015
-
$3.80B(-7.8%)
$15.86B(+0.4%)
Dec 2014
$15.80B(+6.2%)
$4.13B(+4.3%)
$15.79B(+1.1%)
Sep 2014
-
$3.96B(-0.5%)
$15.62B(+2.0%)
Jun 2014
-
$3.97B(+6.4%)
$15.31B(+1.5%)
Mar 2014
-
$3.74B(-5.7%)
$15.08B(+1.3%)
Dec 2013
$14.88B(+10.5%)
$3.96B(+8.7%)
$14.88B(+2.2%)
Sep 2013
-
$3.64B(-2.7%)
$14.57B(+2.2%)
Jun 2013
-
$3.74B(+5.9%)
$14.26B(+2.8%)
Mar 2013
-
$3.54B(-2.9%)
$13.87B(+3.0%)
Dec 2012
$13.46B(+8.7%)
$3.64B(+9.4%)
$13.46B(+2.8%)
Sep 2012
-
$3.33B(-0.7%)
$13.10B(+1.6%)
Jun 2012
-
$3.36B(+7.2%)
$12.90B(+2.1%)
Mar 2012
-
$3.13B(-4.6%)
$12.63B(+2.0%)
Dec 2011
$12.38B(+14.7%)
$3.28B(+4.8%)
$12.38B(+2.9%)
Sep 2011
-
$3.13B(+1.4%)
$12.03B(+3.7%)
Jun 2011
-
$3.09B(+7.2%)
$11.61B(+4.1%)
Mar 2011
-
$2.88B(-1.8%)
$11.14B(+3.2%)
Dec 2010
$10.80B(+13.2%)
$2.93B(+8.5%)
$10.80B(+3.3%)
Sep 2010
-
$2.70B(+2.9%)
$10.46B(+2.9%)
Jun 2010
-
$2.63B(+3.4%)
$10.16B(+2.5%)
Mar 2010
-
$2.54B(-2.1%)
$9.91B(+3.7%)
Dec 2009
$9.54B(+6.7%)
$2.59B(+7.8%)
$9.56B(+4.0%)
Sep 2009
-
$2.40B(+1.1%)
$9.19B(+1.6%)
Jun 2009
-
$2.38B(+8.9%)
$9.05B(+0.6%)
Mar 2009
-
$2.18B(-1.8%)
$9.00B(+0.6%)
Dec 2008
$8.94B(+16.3%)
$2.22B(-1.7%)
$8.95B(+1.1%)
Sep 2008
-
$2.26B(-2.7%)
$8.85B(+3.8%)
Jun 2008
-
$2.33B(+9.1%)
$8.52B(+5.1%)
Mar 2008
-
$2.13B(+0.3%)
$8.11B(+5.3%)
Dec 2007
$7.69B(+17.9%)
$2.13B(+9.6%)
$7.70B(+4.2%)
Sep 2007
-
$1.94B(+1.4%)
$7.39B(+4.3%)
Jun 2007
-
$1.91B(+10.8%)
$7.09B(+4.0%)
Mar 2007
-
$1.73B(-4.8%)
$6.82B(+4.4%)
Dec 2006
$6.52B(+15.9%)
$1.81B(+10.8%)
$6.53B(+5.0%)
Sep 2006
-
$1.64B(-0.2%)
$6.22B(+3.3%)
Jun 2006
-
$1.64B(+13.8%)
$6.02B(+4.2%)
Mar 2006
-
$1.44B(-4.0%)
$5.78B(+2.9%)
Dec 2005
$5.63B(+16.1%)
$1.50B(+4.5%)
$5.62B(+2.1%)
Sep 2005
-
$1.44B(+2.7%)
$5.50B(+4.2%)
Jun 2005
-
$1.40B(+9.5%)
$5.28B(+4.7%)
Mar 2005
-
$1.28B(-7.7%)
$5.04B(+3.8%)
Dec 2004
$4.85B
$1.38B(+13.8%)
$4.86B(+5.0%)
DateAnnualQuarterlyTTM
Sep 2004
-
$1.22B(+5.0%)
$4.62B(+4.6%)
Jun 2004
-
$1.16B(+6.1%)
$4.42B(+3.8%)
Mar 2004
-
$1.09B(-5.3%)
$4.26B(+5.2%)
Dec 2003
$4.04B(+26.3%)
$1.15B(+13.6%)
$4.05B(+6.6%)
Sep 2003
-
$1.02B(+1.8%)
$3.80B(+4.5%)
Jun 2003
-
$997.64M(+13.1%)
$3.64B(+5.5%)
Mar 2003
-
$881.93M(-2.4%)
$3.45B(+7.3%)
Dec 2002
$3.20B(+12.0%)
$903.18M(+5.8%)
$3.21B(+4.1%)
Sep 2002
-
$853.62M(+5.5%)
$3.09B(+4.8%)
Jun 2002
-
$808.91M(+25.1%)
$2.95B(+3.8%)
Mar 2002
-
$646.71M(-16.8%)
$2.84B(-0.5%)
Dec 2001
$2.85B(+11.0%)
$777.25M(+9.0%)
$2.85B(+22.5%)
Sep 2001
-
$712.95M(+1.6%)
$2.33B(+44.1%)
Jun 2001
-
$701.92M(+6.2%)
$1.62B(+76.9%)
Mar 2001
-
$660.99M(+161.9%)
$913.33M(-7.7%)
Dec 2000
$2.57B(-14.1%)
$252.34M(-65.8%)
$989.10M(-33.0%)
Mar 2000
-
$736.77M(-0.4%)
$1.48B(-35.5%)
Dec 1999
$2.99B(+12.0%)
-
-
Jun 1999
-
$739.57M(+5.5%)
$2.29B(+3.2%)
Mar 1999
-
$701.07M(+621.7%)
$2.22B(+4.5%)
Dec 1998
$2.67B(+4.3%)
$97.15M(-87.1%)
$2.12B(-22.2%)
Sep 1998
-
$750.72M(+12.4%)
$2.73B(+4.7%)
Jun 1998
-
$668.15M(+10.4%)
$2.60B(+1.4%)
Mar 1998
-
$605.00M(-13.7%)
$2.57B(+1.2%)
Dec 1997
$2.56B(-0.1%)
$701.25M(+11.8%)
$2.54B(-0.6%)
Sep 1997
-
$627.41M(-0.7%)
$2.55B(-0.3%)
Jun 1997
-
$631.76M(+9.9%)
$2.56B(+1.4%)
Mar 1997
-
$575.07M(-19.7%)
$2.52B(-1.2%)
Dec 1996
$2.57B(+4.7%)
$716.07M(+12.7%)
$2.55B(+4.0%)
Sep 1996
-
$635.32M(+6.3%)
$2.46B(+2.4%)
Jun 1996
-
$597.46M(-1.2%)
$2.40B(-2.2%)
Mar 1996
-
$604.87M(-2.1%)
$2.45B(+1.2%)
Dec 1995
$2.45B(+15.1%)
$617.87M(+6.7%)
$2.42B(+1.2%)
Sep 1995
-
$578.90M(-11.3%)
$2.40B(+1.3%)
Jun 1995
-
$652.47M(+13.4%)
$2.36B(+5.7%)
Mar 1995
-
$575.16M(-2.3%)
$2.24B(+5.3%)
Dec 1994
$2.13B(+11.7%)
$588.55M(+7.4%)
$2.13B(-2.0%)
Sep 1994
-
$547.95M(+4.2%)
$2.17B(+4.0%)
Jun 1994
-
$525.81M(+13.5%)
$2.09B(+2.0%)
Mar 1994
-
$463.15M(-26.8%)
$2.04B(+2.3%)
Dec 1993
$1.90B(+6.4%)
$633.01M(+36.2%)
$2.00B(+9.9%)
Sep 1993
-
$464.66M(-4.0%)
$1.82B(+0.6%)
Jun 1993
-
$484.02M(+15.9%)
$1.81B(+1.9%)
Mar 1993
-
$417.53M(-7.9%)
$1.78B(-0.3%)
Dec 1992
$1.79B(+21.3%)
$453.56M(-0.2%)
$1.78B(-0.8%)
Sep 1992
-
$454.35M(+0.8%)
$1.80B(+5.8%)
Jun 1992
-
$450.60M(+6.3%)
$1.70B(+7.1%)
Mar 1992
-
$423.75M(-9.3%)
$1.58B(+2.4%)
Dec 1991
$1.48B(+12.3%)
$467.25M(+31.5%)
$1.55B(+4.3%)
Sep 1991
-
$355.38M(+5.1%)
$1.48B(+1.5%)
Jun 1991
-
$338.30M(-12.5%)
$1.46B(+1.4%)
Mar 1991
-
$386.54M(-4.3%)
$1.44B(+6.6%)
Dec 1990
$1.31B(+29.7%)
$403.94M(+20.9%)
$1.35B(+7.9%)
Sep 1990
-
$334.06M(+5.1%)
$1.25B(+8.7%)
Jun 1990
-
$317.76M(+6.8%)
$1.15B(+7.8%)
Mar 1990
-
$297.53M(-2.4%)
$1.07B(+2.1%)
Dec 1989
$1.01B(+29.6%)
$304.81M(+30.4%)
$1.05B(+6.7%)
Sep 1989
-
$233.75M(-0.0%)
$981.87M(+5.2%)
Jun 1989
-
$233.82M(-15.0%)
$933.24M(+2.3%)
Mar 1989
-
$275.14M(+15.0%)
$912.23M(+10.9%)
Dec 1988
$781.71M(+8.8%)
$239.16M(+29.2%)
$822.23M(+3.5%)
Sep 1988
-
$185.12M(-13.0%)
$794.23M(+0.6%)
Jun 1988
-
$212.81M(+15.0%)
$789.74M(+5.5%)
Mar 1988
-
$185.13M(-12.3%)
$748.69M(+1.2%)
Dec 1987
$718.36M(+38.0%)
$211.16M(+16.9%)
$740.04M(+11.0%)
Sep 1987
-
$180.64M(+5.2%)
$666.80M(+8.3%)
Jun 1987
-
$171.75M(-2.7%)
$615.56M(+6.6%)
Mar 1987
-
$176.49M(+28.0%)
$577.58M(+11.1%)
Dec 1986
$520.54M(+33.8%)
$137.92M(+6.6%)
$519.67M(+5.4%)
Sep 1986
-
$129.40M(-3.3%)
$493.06M(+7.3%)
Jun 1986
-
$133.77M(+12.8%)
$459.60M(+9.2%)
Mar 1986
-
$118.58M(+6.5%)
$421.07M(+6.6%)
Dec 1985
$389.06M(+6.9%)
$111.30M(+16.0%)
$394.99M(+5.4%)
Sep 1985
-
$95.94M(+0.7%)
$374.78M(+1.2%)
Jun 1985
-
$95.24M(+3.0%)
$370.38M(+1.1%)
Mar 1985
-
$92.51M(+1.5%)
$366.30M(+0.1%)
Dec 1984
$363.87M(-0.9%)
$91.09M(-0.5%)
$365.94M(+33.1%)
Sep 1984
-
$91.54M(+0.4%)
$274.84M(+49.9%)
Jun 1984
-
$91.16M(-1.1%)
$183.30M(+98.9%)
Mar 1984
-
$92.14M
$92.14M
Dec 1983
$367.13M(+14.2%)
-
-
Dec 1982
$321.43M(+2.6%)
-
-
Dec 1981
$313.31M(+11.8%)
-
-
Dec 1980
$280.29M
-
-

FAQ

  • What is Novo Nordisk A/S annual revenue?
  • What is the all time high annual revenue for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual revenue year-on-year change?
  • What is Novo Nordisk A/S quarterly revenue?
  • What is the all time high quarterly revenue for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly revenue year-on-year change?
  • What is Novo Nordisk A/S TTM revenue?
  • What is the all time high TTM revenue for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM revenue year-on-year change?

What is Novo Nordisk A/S annual revenue?

The current annual revenue of NVO is $42.12B

What is the all time high annual revenue for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual revenue is $42.12B

What is Novo Nordisk A/S annual revenue year-on-year change?

Over the past year, NVO annual revenue has changed by +$8.41B (+24.97%)

What is Novo Nordisk A/S quarterly revenue?

The current quarterly revenue of NVO is $11.68B

What is the all time high quarterly revenue for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly revenue is $12.25B

What is Novo Nordisk A/S quarterly revenue year-on-year change?

Over the past year, NVO quarterly revenue has changed by +$1.86B (+18.96%)

What is Novo Nordisk A/S TTM revenue?

The current TTM revenue of NVO is $45.45B

What is the all time high TTM revenue for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM revenue is $45.45B

What is Novo Nordisk A/S TTM revenue year-on-year change?

Over the past year, NVO TTM revenue has changed by +$8.05B (+21.52%)
On this page